↓ Skip to main content

Rare Diseases Epidemiology

Overview of attention for book
Cover of 'Rare Diseases Epidemiology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Rare Diseases – Avoiding Misperceptions and Establishing Realities: The Need for Reliable Epidemiological Data
  3. Altmetric Badge
    Chapter 2 Rare Diseases Epidemiology Research
  4. Altmetric Badge
    Chapter 3 Evidence-Based Medicine and Rare Diseases
  5. Altmetric Badge
    Chapter 4 Prevention, Diagnosis and Services
  6. Altmetric Badge
    Chapter 5 The Importance of Case Reports in Advancing Scientific Knowledge of Rare Diseases
  7. Altmetric Badge
    Chapter 6 Patient registries: utility, validity and inference.
  8. Altmetric Badge
    Chapter 7 Biobanking in Rare Disorders
  9. Altmetric Badge
    Chapter 8 Evaluation of the validity and utility of genetic testing for rare diseases.
  10. Altmetric Badge
    Chapter 9 Rare Diseases Epidemiology
  11. Altmetric Badge
    Chapter 10 Statistical Methods for the Geographical Analysis of Rare Diseases
  12. Altmetric Badge
    Chapter 11 Clinical Trials and Rare Diseases
  13. Altmetric Badge
    Chapter 12 A Regulatory Overview About Rare Diseases
  14. Altmetric Badge
    Chapter 13 Rare Diseases Epidemiology
  15. Altmetric Badge
    Chapter 14 Rare Diseases Social Epidemiology: Analysis of Inequalities
  16. Altmetric Badge
    Chapter 15 Quality of Life and Rare Diseases
  17. Altmetric Badge
    Chapter 16 Cost of illness and economic evaluation in rare diseases
  18. Altmetric Badge
    Chapter 17 The Burden of Rare Cancers in Europe
  19. Altmetric Badge
    Chapter 18 Hereditary Channelopathies in Neurology
  20. Altmetric Badge
    Chapter 19 Osteochondral Diseases and Fibrodysplasia Ossificans Progressiva
  21. Altmetric Badge
    Chapter 20 The Prevalence of Congenital Anomalies in Europe
  22. Altmetric Badge
    Chapter 21 Rare Autoimmune Diseases
  23. Altmetric Badge
    Chapter 22 Epidemiology of Rare Anaemias in Europe
  24. Altmetric Badge
    Chapter 23 Inherited Metabolic Rare Disease
  25. Altmetric Badge
    Chapter 24 Rare Diseases Epidemiology
  26. Altmetric Badge
    Chapter 25 Creating a European Union Framework for Actions in the Field of Rare Diseases
  27. Altmetric Badge
    Chapter 26 National Plans and Strategies on Rare Diseases in Europe
  28. Altmetric Badge
    Chapter 27 Ethical Aspects on Rare Diseases
  29. Altmetric Badge
    Chapter 28 Advocacy Groups and Their Role in Rare Diseases Research
Overall attention for this book and its chapters
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
2 blogs
twitter
12 X users

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
185 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rare Diseases Epidemiology
Published by
Advances in experimental medicine and biology, January 2010
DOI 10.1007/978-90-481-9485-8
ISBNs
978-9-04-819484-1, 978-9-04-819485-8, 978-9-40-073338-1
Authors

Posada de la Paz, Manuel, Groft, Stephen C

Editors

Manuel Posada de la Paz, Stephen C. Groft

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 5 3%
United States 4 2%
Korea, Republic of 2 1%
Netherlands 1 <1%
Belgium 1 <1%
Canada 1 <1%
Unknown 171 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 18%
Student > Master 31 17%
Student > Bachelor 25 14%
Student > Ph. D. Student 23 12%
Other 14 8%
Other 42 23%
Unknown 17 9%
Readers by discipline Count As %
Medicine and Dentistry 72 39%
Agricultural and Biological Sciences 21 11%
Biochemistry, Genetics and Molecular Biology 17 9%
Social Sciences 9 5%
Economics, Econometrics and Finance 6 3%
Other 37 20%
Unknown 23 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2023.
All research outputs
#1,816,864
of 26,017,215 outputs
Outputs from Advances in experimental medicine and biology
#241
of 5,312 outputs
Outputs of similar age
#8,020
of 177,915 outputs
Outputs of similar age from Advances in experimental medicine and biology
#3
of 87 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,312 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,915 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.